Page last updated: 2024-12-06
quinaldofur
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
quinaldofur: used in treatment of bovine mastitis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 71946 |
CHEMBL ID | 2106805 |
SCHEMBL ID | 668409 |
MeSH ID | M0059617 |
Synonyms (22)
Synonym |
---|
nifuroquine |
4-(5-nitrofuran-2-yl)-1-oxidoquinolin-1-ium-2-carboxylic acid |
57474-29-0 |
quinaldofur |
CHEMBL2106805 |
4-(5-nitro-2-furyl)quinaldic acid 1-oxide |
4-(5'-nitrofuryl)quinaldinic acid n-oxide |
nifuroquinum [inn-latin] |
nifuroquinum |
unii-54t0t0f4o2 |
nifuroquina |
54t0t0f4o2 , |
abimasten |
einecs 260-755-9 |
4-(5-nitro-2-furyl)-2-chinolincarbonaeure-1-oxid |
nifuroquine [inn:ban] |
nifuroquina [inn-spanish] |
nifuroquine [mi] |
nifuroquine [inn] |
SCHEMBL668409 |
DTXSID20206087 |
Q27261242 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.38
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.38) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |